8,458 Shares in The Clorox Company $CLX Purchased by Soltis Investment Advisors LLC

Soltis Investment Advisors LLC acquired a new stake in The Clorox Company (NYSE:CLX) in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 8,458 shares of the company’s stock, valued at approximately $685,000.

A number of other hedge funds have also recently added to or reduced their stakes in CLX. Ancora Advisors LLC bought a new stake in shares of Clorox during the second quarter worth $28,000. Avalon Trust Co bought a new position in shares of Clorox in the 2nd quarter valued at $29,000. Markowski Investments bought a new position in shares of Clorox in the 2nd quarter valued at $30,000. Root Financial Partners LLC lifted its stake in shares of Clorox by 83.8% in the 1st quarter. Root Financial Partners LLC now owns 318 shares of the company’s stock valued at $33,000 after acquiring an additional 145 shares during the last quarter. Finally, Pension & Wealth Management Advisors Inc. acquired a new stake in shares of Clorox during the 3rd quarter valued at $26,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Key Clorox News

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: New CEO appointed: Clorox named Fabian Garcia, a veteran consumer-products executive from Unilever, as CEO and chair effective January 5, 2027. His experience could help strengthen brand execution and support a turnaround after a comprehensive search. Matthew Shattock will resume his role as independent chair, while Linda Rendle is stepping down for health reasons. Clorox Appoints Fabian Garcia as CEO
• Positive Sentiment: Potential earnings support: Analysts expect fiscal first-quarter 2027 results to benefit from product innovation, brand investments and the contribution from GOJO, the hand-care business acquired by Clorox. A stronger-than-expected report could provide a near-term catalyst. Clorox’s Q1 Earnings Coming Up: Key Insights for Investors
• Neutral Sentiment: Valuation is being debated: Recent commentary suggests CLX may be fairly valued based on expected earnings, while the incoming CEO could make the stock appear inexpensive if he improves growth and profitability. Investors are likely to focus on guidance and the pace of recovery rather than valuation alone. Clorox Stock Looks About Right Based on Earnings
• Negative Sentiment: Profitability and dividend risks remain: Higher costs, cautious consumer spending and potential pressure on margins may limit the benefit from innovation and GOJO. Analysts also view the dividend as facing a more difficult test, making cash flow and management’s outlook key issues in the earnings release. Clorox: An Easy Quarter Ahead, But a Harder Test for the Dividend

Wall Street Analyst Weigh In

CLX has been the topic of a number of research reports. Jefferies Financial Group lowered Clorox from a “buy” rating to a “hold” rating and reduced their price objective for the stock from $125.00 to $98.00 in a research report on Tuesday, July 28th. Wall Street Zen cut Clorox from a “hold” rating to a “sell” rating in a report on Saturday, October 3rd. Weiss Ratings reiterated a “hold (c-)” rating on shares of Clorox in a research report on Tuesday, October 6th. JPMorgan Chase & Co. cut their price target on Clorox from $95.00 to $83.00 and set an “underweight” rating on the stock in a research note on Monday, October 19th. Finally, Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $95.00 price target on shares of Clorox in a research note on Monday, October 19th. Eleven analysts have rated the stock with a Hold rating and five have given a Sell rating to the company’s stock. Based on data from MarketBeat, Clorox has a consensus rating of “Reduce” and a consensus target price of $93.57.

Clorox Trading Down 0.7%

Shares of NYSE CLX opened at $88.01 on Friday. The firm has a 50 day moving average price of $88.61 and a two-hundred day moving average price of $100.01. The stock has a market cap of $10.64 billion, a P/E ratio of 18.26, a price-to-earnings-growth ratio of 2.94 and a beta of 0.59. The Clorox Company has a 52-week low of $79.12 and a 52-week high of $128.90. The company has a debt-to-equity ratio of 15.80, a quick ratio of 0.38 and a current ratio of 0.66.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Monday, August 3rd. The company reported $1.66 EPS for the quarter, topping analysts’ consensus estimates of $1.64 by $0.02. Clorox had a net margin of 8.74% and a return on equity of 522.23%. The company had revenue of $1.95 billion for the quarter, compared to analyst estimates of $1.91 billion. During the same quarter in the previous year, the business earned $2.87 earnings per share. Clorox’s revenue was down 2.0% compared to the same quarter last year. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. As a group, equities analysts forecast that The Clorox Company will post 5.66 EPS for the current year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Wednesday, October 28th will be given a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 5.7%. The ex-dividend date of this dividend is Wednesday, October 28th. Clorox’s dividend payout ratio (DPR) is currently 103.73%.

About Clorox

The Clorox Company, founded in 1913 and headquartered in Oakland, California, is a consumer and professional products company. It began with household bleach and has expanded into a portfolio of brands serving cleaning, household, personal care, food, and professional markets.

Its brands include Clorox disinfecting and cleaning products, Pine-Sol cleaners, Liquid-Plumr drain care, Kingsford charcoal, Fresh Step and Scoop Away cat litter, Hidden Valley dressings and dips, Brita water filtration products, and Burt’s Bees personal care items.